Analysis of CDKN1A polymorphisms: markers of cancer susceptibility?
- 15 April 2003
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 142 (2) , 92-98
- https://doi.org/10.1016/s0165-4608(02)00839-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblastsCancer Letters, 2002
- RB regulates transcription of the p21/WAF1/CIP1 geneOncogene, 2001
- p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivoOral Oncology, 1998
- p73 is a human p53-related protein that can induce apoptosisNature, 1997
- Ethanol upregulates the expression of p21WAF1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cellsOncogene, 1997
- Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPlNature, 1997
- Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint controlCell, 1995
- Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.Proceedings of the National Academy of Sciences, 1995
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993